BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11277656)

  • 1. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer.
    Abu-Rustum NR; Lee S; Correa A; Massad LS
    Gynecol Oncol; 2001 Apr; 81(1):88-91. PubMed ID: 11277656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone.
    Ohno T; Kato S; Wakatsuki M; Noda SE; Murakami C; Nakamura M; Tsujii H
    Gynecol Oncol; 2006 Oct; 103(1):94-9. PubMed ID: 16527337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
    Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens.
    Nagy V; Todor N; Coza O; Ordeanu C; Ghilezan N
    J BUON; 2007; 12(3):389-94. PubMed ID: 17918294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
    Mell LK; Kochanski JD; Roeske JC; Haslam JJ; Mehta N; Yamada SD; Hurteau JA; Collins YC; Lengyel E; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1356-65. PubMed ID: 16757127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma.
    Mitsuhashi A; Uno T; Tanaka N; Suzuka K; Tate S; Yamazawa K; Matsui H; Yamamoto S; Ito H; Sekiya S
    Gynecol Oncol; 2005 Jan; 96(1):194-7. PubMed ID: 15589600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External beam radiotherapy and high-dose brachytherapy combined with cisplatin and paclitaxel in patients with advanced cervical carcinoma.
    Petera J; Odrázka K; Frgala T; Spacek J
    Gynecol Oncol; 2005 Nov; 99(2):334-8. PubMed ID: 16023181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of chemoradiation with radiation as postoperative adjuvant therapy in cervical cancer patients with intermediate-risk factors.
    Kim K; Kang SB; Chung HH; Kim JW; Park NH; Song YS
    Eur J Surg Oncol; 2009 Feb; 35(2):192-6. PubMed ID: 18490129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies.
    Mundt AJ; Rotmensch J; Waggoner SE; Yamada SD; Fleming GF
    Gynecol Oncol; 2004 Mar; 92(3):801-5. PubMed ID: 14984944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
    Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
    Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
    Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
    Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of hemoglobin level with survival in cervical carcinoma patients treated with concurrent cisplatin and radiotherapy: a Gynecologic Oncology Group Study.
    Winter WE; Maxwell GL; Tian C; Sobel E; Rose GS; Thomas G; Carlson JW
    Gynecol Oncol; 2004 Aug; 94(2):495-501. PubMed ID: 15297194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Yang SN; Lin FJ
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1370-7. PubMed ID: 16979836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of concurrent chemoradiation in comparison with radiation alone in locally advanced cervical cancer.
    Manusirivithaya S; Sripramote M; Tangjitgamol S; Sanjareonsuttikul N; Pisarnturakit P
    J Med Assoc Thai; 2005 Aug; 88(8):1035-44. PubMed ID: 16404829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyradiculopathy post-concomitant chemoradiation for carcinoma of the uterine cervix treated with pelvic and para-aortic fields.
    Coulombe G; Thiessen B; Balkwill S; Aquino-Parsons C
    Gynecol Oncol; 2005 Dec; 99(3):774-7. PubMed ID: 16188304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic events in patients treated with definitive chemotherapy and radiation therapy for invasive cervical cancer.
    Jacobson GM; Kamath RS; Smith BJ; Goodheart MJ
    Gynecol Oncol; 2005 Feb; 96(2):470-4. PubMed ID: 15661237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.